#1661 - Rick Doblin cover

#1661 - Rick Doblin

NaN minutesEpisode #1661
Rick Doblin

Rick Doblin is the founder and Executive Director of the non-profit psychedelic research and educational organization, the Multidisciplinary Association for Psychedelic Studies (MAPS).

Episode Timestamps

  • Psychedelics in Therapy and Support for Police Officers and Prisoners

    • Discussion on the benefits of using psychedelics in therapy for individuals like soldiers with PTSD
    • Exploration of administering MDMA therapy to police officers and prisoners to help with trauma
    • Revelation about the importance of aftercare and group support post-psychedelic experiences
  • Challenges of Reintegration and Long-Term Therapy

    • Insights into the challenges prisoners face after release and the difficulties of reintegration into society
    • Explanation of the need for ongoing support and therapy post-psychedelic experience for long-term success
    • Illustration of the neuroplastic effects of psychedelics and the importance of creating new pathways post-treatment
  • Realization of Insecurities and Insights from MDMA Experience

    • Reflecting on the impact of insecurities in everyday interactions
    • Sharing the experience of openness and lack of fear during MDMA session
    • Discussions on the potential benefits of psychedelic experiences for prisoners with traumatic backgrounds
  • Journey through Underground Activities and Profound Psychedelic Realizations

    • Exploration of early underground activities against the communist regime
    • Insights from a DMT experience revealing interconnectedness and capacity for evil
    • Personal reflections on confronting the notion of evil within oneself through psychedelic experiences
  • Ketamine Experience and Insights on Hitler's Influence

    • Narrative of a ketamine experience and feeling both present and removed
    • Realization about the need for mass mental health to counter evil ideologies
    • Discussion on Hitler's drug use and its impact on his actions and world events
  • Discussion on Drugs, Neurochemistry, and Drug Policy Reform

    • Insights on the impact of drugs on behavior and mental processes
    • Conversation about the brain being a 'drug factory' and the significance of neurochemistry
    • Advocacy for drug policy reform and the example of Carl Hart's views on responsible drug use
  • Work Environment at MAPS and the Emphasis on Performance over Drug Testing

    • MAPS employs around 120 people, emphasizing a performance-based approach over drug testing.
    • Employees are permitted to engage in 'smokable tasks' like smoking pot during work if it enhances their performance.
    • The company values performance and creativity, allowing for non-traditional methods to optimize work output.
  • Psychedelics, Creativity, and Emotional Healing

    • Discussion on how psychedelics such as marijuana can enhance creativity by widening associations in the brain.
    • Exploration of MDMA's therapeutic effects in helping individuals address trauma and achieve self-acceptance.
    • Vision for the future of psychedelic therapy centers to aid in emotional education and mental health reform.
  • Impact of Technology on Humanity and the Call for a New Mode of Thinking

    • Discussion on the quote "Our technology has exceeded our humanity" often attributed to Albert Einstein
    • Exploration of Einstein's quote on the need for a new mode of thinking in the face of catastrophic consequences of technological advancements
    • Emphasis on the importance of fostering a universal spiritual connection to prevent disastrous human behaviors like genocide and racism
  • The Educational Paradigm Shift Towards Mental Health and Psychedelic Exploration

    • Critique on traditional education systems and the lack of emphasis on mental and physical well-being
    • Personal narrative on the transformative effects of psychedelics and mental health exploration
    • Discussion on the importance of individual curiosity and emotional development in education
  • Personal Journey and Integration Work

    • Reflection on the confusion and turbulent times of the late 60s and early 70s
    • Transition back home, building a handball court, and entering the construction business
    • A decade-long period of self-reflection and emotional growth with occasional psychedelic experiences
  • Introduction to MDMA and Political Engagement

    • Encounter with MDMA and its therapeutic potential pre-backlash era
    • Involvement in introducing MDMA to individuals like Lester Grinspoon for therapeutic use
    • Influence of Terrence McKenna and political activism in response to DEA crackdown
  • Psychedelic Research and the Fruitfulness of Mystical Experiences

    • Discussion on the significance of the 'fruits test' in evaluating mystical experiences
    • Anecdotes about Walter Pankie's research and follow-up studies on Good Friday service participants
    • Observations on how mystical experiences influenced societal movements like environmental protection and civil rights
  • Mainstreaming Psychedelics and Historical Context

    • Exploration of the historical suppression of psychedelic traditions by religious and political authorities
    • Insights into the emergence of psychedelic research in Western culture
    • Mention of the military's past interest in psychedelic substances for potential tactical uses and the current focus on non-psychedelic variants for therapeutic purposes
  • The Push for Psychedelic Therapy in Treating PTSD

    • Discussion on the importance of therapists in psychedelic therapy despite the desire for a pill-based treatment
    • Efforts to secure funding and bipartisan support for psychedelic research in PTSD treatment
    • The historical background of psychedelic therapy for trauma and the current focus on MDMA as a promising tool
  • Expanding Research and Treatment Globally

    • Collaboration with politicians like Congressman Dan Crenshaw and the shifting perceptions towards psychedelic therapy
    • Initiatives to globalize MDMA therapy for PTSD and ongoing research efforts in countries like the Netherlands, Israel, and Canada
    • Exploration of treatment possibilities for various trauma survivors beyond military contexts
  • Psychedelics and Changing Cultural Attitudes

    • Discussion about reintroducing psychedelics like MDMA to Western culture to promote spiritualism and reduce trauma
    • Need to re-engineer the cultural narrative around drugs from a negative to a positive perspective
    • Anecdote about giving marijuana to a daughter and cultural responses to drug use
  • Challenges and Benefits of Psychedelic Experiences

    • Differentiating between bad trips due to resistance and difficult trips that can be productive with support
    • Examples of challenging experiences leading to healing and transformation with MDMA-assisted therapy
    • Discussion on variability in psychedelic experiences based on individual reactions and mindset
  • CBD with THC Incident and Marijuana Monopoly

    • Anecdote about a lady who took CBD with THC, thought she was dying, and police had to ride it out
    • Discussion on the federal government monopoly on the supply of DEA marijuana since 1968
    • Efforts to end the DEA marijuana monopoly, including the legal battle and license issuance
  • Marijuana Research and Federal Legalization Predictions

    • Historical account of efforts to end the federal monopoly on DEA marijuana production
    • Discussion on state initiatives and federal progress towards marijuana legalization
    • Prediction for federal law changes on marijuana prohibition in 2025
  • Marijuana Laws and Usage in Texas

    • Discussion about the decriminalization of marijuana in Austin, Texas
    • Exploration of the misconceptions surrounding marijuana users and the benefits Joe Rogan sees in using marijuana
    • Anecdotes about using marijuana before running the New York Marathon and in the workplace
  • Marijuana in Jujitsu: Enhancing Performance and Changing Perceptions

    • Insights into the connection between marijuana usage and performance in jujitsu
    • Description of how being high can enhance performance during jujitsu sessions
    • Discussion on the history of marijuana use among high-level jujitsu practitioners and the contrast with stereotypes about marijuana users
  • Understanding Drugs as Tools and Importance of Relationship with them

    • Discussion on viewing drugs like marijuana and psychedelics as tools based on how they are used
    • Importance of the relationship and intentions behind using drugs over categorizing them as good or bad
    • Examples of how drugs like MDMA can serve both recreational and therapeutic purposes based on context
  • Path to Commercialization and Global Expansion of MDMA Research

    • Exploration of FDA incentives for research on off-patent drugs like MDMA
    • Introduction of Benefit Corporation model for maximizing public benefit over profit in selling MDMA
    • Initiatives towards globalizing MDMA research notably in Europe and conflict-affected regions for trauma treatment
  • Commercializing MDMA as Medicine: Current Situation and Future Plans

    • Discussion about the government's role in studying MDMA literature for potential rescheduling in Texas and all 50 states
    • Overview of the challenges and estimated costs for commercializing MDMA by MAPS
    • Exploration of the potential profits and global availability of MDMA through MAPS' efforts
  • Regulatory Challenges and Resolving FDA Disagreements

    • Details on FDA challenges related to therapist protocol approval and the importance of data exclusivity
    • Narrative on MAPS' efforts to dispute FDA requirements and win permission for MDMA therapy studies
    • Insights on the sourcing of medical-grade MDMA from various countries and companies for MAPS' research
  • Path to Legalization of Psychedelics and Therapeutic Clinics

    • Discussion on the potential path towards licensed legalization of psilocybin, MDMA, LSD by 2035
    • Comparison to the slow progress of marijuana legalization despite medical use since 1996
    • Importance of stories in motivating policy change and the role of FDA data in medical legalization
  • Therapeutic Dosing and Study Insights on MDMA

    • Testing of various doses of MDMA in therapy sessions for PTSD patients
    • Discovery of lower effective dose than anticipated and implications for study design
    • Modifying therapy protocol based on study findings to optimize therapeutic outcomes
  • Drug Approval Process and Study Design

    • Description of the process and agreements made with FDA and European Medicines Agency for drug approval studies
    • Inclusion of Syrian refugees and migrants in phase three study in Europe
    • Utilization of CAPS-5 measure developed by Boston VA to assess PTSD symptoms
  • Therapy Sessions and Therapist Variability

    • Discussion on therapy sessions involving MDMA and self-healing experiences
    • Exploration of therapist variability and site-to-site variations in results
    • Adherence criteria and standardized approach for therapists in administering therapy
  • PTSD Treatment with MDMA Therapy and Challenges with Insurance Coverage

    • Discussion on the effectiveness of MDMA therapy in treating PTSD, with phase two and phase three study results.
    • Challenges related to insurance coverage for the therapy and the need for long-term durability in treatment.
    • Comparison between MDMA therapy which aims for lasting results vs. traditional drug treatments like SSRIs.
  • Therapeutic Potential of MDMA in Prisons and Political Reconciliation Efforts

    • Exploration of using MDMA therapy for recently paroled individuals and potential to reduce recidivism rates.
    • Discussion on implementing therapy in prison environments to address deep-seated traumas and improve quality of life.
    • Initiatives focusing on political reconciliation using psychedelics, such as MDMA, in conflict zones like Israeli-Palestinian contexts.
  • Psychedelics and Neural Growth for Traumatic Brain Injury (TBI) and PTSD

    • Discussion on the effects of MDMA and psilocybin on neuroplasticity and neural growth
    • Exploration of the potential benefits of psychedelics in treating TBI and PTSD
    • Efforts to raise funds for research and development in partnership with other companies
  • Fundraising Strategies and Support for Maps.org

    • Consideration of fundraising methods such as philanthropy and donations for Maps.org
    • Exploring partnerships with companies interested in MDMA for various indications
    • Encouragement for donations through methods like mailing checks or donating stocks
© Copyright 2024, All Rights Reserved, created by @mr_johnnybgoode